Log in
Enquire now
‌

US Patent 10214775 Prostate cancer associated circulating nucleic acid biomarkers

Patent 10214775 was granted and assigned to Chronix Biomedical on February, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Chronix Biomedical
Chronix Biomedical
Current Assignee
Chronix Biomedical
Chronix Biomedical
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10214775
Patent Inventor Names
Julia Beck0
Ekkehard Schutz0
Howard Urnovitz0
Date of Patent
February 26, 2019
Patent Application Number
14414882
Date Filed
December 7, 2012
Patent Primary Examiner
‌
G Steven Vanni
Patent abstract

The invention provides methods and reagents for diagnosing prostate cancer that are based on the detection of biomarkers in the circulating nucleic acids from a patient to be evaluated.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10214775 Prostate cancer associated circulating nucleic acid biomarkers

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.